KRISTYN LYONS: Open Payments
NPI 1053355479 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 34 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $256 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $144 |
| ABBVIE INC. | 9 | $138 |
| Phathom Pharmaceuticals, Inc. | 8 | $119 |
| Madrigal Pharmaceuticals | 4 | $117 |
| PFIZER INC. | 5 | $111 |
| Aimmune Therapeutics, Inc. | 3 | $93 |
| Gilead Sciences, Inc. | 1 | $29 |
| Echosens North America, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Braintree Laboratories, Inc. | 1 | $20 |
Products named: General - Biliary Devices, VOQUEZNA, REZDIFFRA, VOWST, CREON, VELSIPITY, LINZESS, SKYRIZI.
Industry payments across MD — which companies pay providers there.
